AVASTIN /01555201 for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where AVASTIN /01555201 was used for Lung neoplasm malignant.
Most Reported Side Effects for AVASTIN /01555201
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 9 | 22.0% | 4 | 2 |
| Diarrhoea | 8 | 19.5% | 0 | 3 |
| Death | 6 | 14.6% | 6 | 0 |
| Fatigue | 6 | 14.6% | 2 | 1 |
| Nausea | 5 | 12.2% | 1 | 2 |
| Rash | 5 | 12.2% | 0 | 2 |
Other Indications for AVASTIN /01555201
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)